ConductScience.org, home

Paper32011104

The challenge of HIV treatment in an era of polypharmacy.

Back D and 1 other. J Int AIDS Soc, 2020. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. The challenge of HIV treatment in an era of polypharmacy. Papers, record 32011104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32011104

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The challenge of HIV treatment in an era of polypharmacy.
PubMed
Journal
J Int AIDS Soc
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2024-03-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Back DDavidhttps://orcid.org/0000-0002-7381-4799
2Marzolini CCatia

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
HIV InfectionsMajor topic
PolypharmacyMajor topic
Age Factors
Aged
Drug Interactions
Humans
Inappropriate Prescribing
Medication Reconciliation

Source PubMed

Download CSV of topics

References114

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123681436Clinical perspective on drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor rilpivirine.AIDS Rev2013https://conductscience.org/library/papers/23681436PubMed
232011104The challenge of HIV treatment in an era of polypharmacy.J Int AIDS Soc2020https://conductscience.org/library/papers/32011104PubMed
329543653Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.AIDS2018https://conductscience.org/library/papers/29543653PubMed
427686116Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study.Infect Dis (Lond)2017https://conductscience.org/library/papers/27686116PubMed
522864103Pharmacotherapy considerations in elderly adults.South Med J2012https://conductscience.org/library/papers/22864103PubMed
627747723Postoperative Bleeding After Administration of a Single Dose of Rivaroxaban to a Patient Receiving Antiretroviral Therapy.Drug Saf Case Rep2015https://conductscience.org/library/papers/27747723PubMed
729023938A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.Pharmacotherapy2017https://conductscience.org/library/papers/29023938PubMed
812716797Polypharmacy and medication adherence in patients with type 2 diabetes.Diabetes Care2003https://conductscience.org/library/papers/12716797PubMed
921680580Ageing with HIV: medication use and risk for potential drug-drug interactions.J Antimicrob Chemother2011https://conductscience.org/library/papers/21680580PubMed
1024651857Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.PLoS One2014https://conductscience.org/library/papers/24651857PubMed
1123435690Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.J Antimicrob Chemother2013https://conductscience.org/library/papers/23435690PubMed
1226544766The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients.AIDS Patient Care STDS2016https://conductscience.org/library/papers/26544766PubMed
1329903786Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.BMJ Open2018https://conductscience.org/library/papers/29903786PubMed
1426436616Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.Ann Intern Med2015https://conductscience.org/library/papers/26436616PubMed
1526916628Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.Adv Drug Deliv Rev2016https://conductscience.org/library/papers/26916628PubMed
1629325033Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States.Clin Infect Dis2018https://conductscience.org/library/papers/29325033PubMed
1720921313Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20921313PubMed
1828501495Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.Lancet HIV2017https://conductscience.org/library/papers/28501495PubMed
1923590676Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.HIV Med2013https://conductscience.org/library/papers/23590676PubMed
2026446832American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.J Am Geriatr Soc2015https://conductscience.org/library/papers/26446832PubMed

See all 114 referencesDownload CSV of references

Cited by91

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
42797429Need for Medication Review and Deprescribing in People Living with HIV: A Longitudinal Observational Study.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797429PubMed
42728472Prevalence and Severity of Potential Drug-Drug Interactions in People Living with HIV on Antiretroviral Therapy in the United States.Infect Dis Ther2026https://conductscience.org/library/papers/42728472PubMed
42356190Prevalence of Autoimmune Diseases in Individuals Living with HIV in Korea: A Nationwide Population-Based Study.Medicina (Kaunas)2026https://conductscience.org/library/papers/42356190PubMed
42299479American Geriatrics Society Position Statement: Advancing the Healthcare of Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, and More Older Adults.J Am Geriatr Soc2026https://conductscience.org/library/papers/42299479PubMed
42048495Machine Learning in HIV Care and Antiretroviral Therapy: Systematic Review.J Med Internet Res2026https://conductscience.org/library/papers/42048495PubMed
42005687
Prevalence, Patterns, and Factors Associated With Adverse Drug Reactions Among People Living With HIV Receiving Antiretroviral Therapy at a Secondary Healthcare Facility in Ghana: A Retrospective Cross-Sectional Study.
Health Sci Rep2026https://conductscience.org/library/papers/42005687PubMed
41910934Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.Adv Ther2026https://conductscience.org/library/papers/41910934PubMed
41872027Current perspectives and emerging directions in research and practice: highlights from the 15th Annual International Workshop on Aging and HIV.J Gerontol A Biol Sci Med Sci2026https://conductscience.org/library/papers/41872027PubMed
41725022Anticholinergic burden interacts with age and AIDS history to amplify frailty in people with HIV.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41725022PubMed
41601973Association of medication regimen complexity index with ADRs in HIV/AIDS patients: a retrospective cohort study.Front Pharmacol2025https://conductscience.org/library/papers/41601973PubMed
41233738Prevalence of potentially inappropriate medications in people living with HIV: a systematic review and meta-analysis.BMC Infect Dis2025https://conductscience.org/library/papers/41233738PubMed
41121455Polypharmacy in HIV: Rethinking what counts and why it matters.HIV Med2026https://conductscience.org/library/papers/41121455PubMed
41059201Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium.Front Pharmacol2025https://conductscience.org/library/papers/41059201PubMed
40641568EVALUATION OF SCREENING TOOL OF OLDER PEOPLE'S PRESCRIPTIONS (STOPP) CRITERIA IN AN URBAN COHORT OF OLDER PEOPLE WITH HIV.Pharmacoepidemiology2025https://conductscience.org/library/papers/40641568PubMed
40518723Clinical Evaluation of Drug-Drug Interactions Between Bictegravir and Strong Inhibitors/Inducers of the CYP3A4, UGT1A1, or P-gp Pathways.J Clin Pharmacol2025https://conductscience.org/library/papers/40518723PubMed
40485234Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility survey.HIV Med2025https://conductscience.org/library/papers/40485234PubMed
40431704TAR RNA Mimicry of INI1 and Its Influence on Non-Integration Function of HIV-1 Integrase.Viruses2025https://conductscience.org/library/papers/40431704PubMed
40354016Treatment of Advanced HIV in the Modern Era.Drugs2025https://conductscience.org/library/papers/40354016PubMed
40229403Analysis of risk factors of social frailty in older adults living with HIV/AIDS.Sci Rep2025https://conductscience.org/library/papers/40229403PubMed
40195841Experiences of Older People Living with Human Immunodeficiency Virus Comorbidity Attending Coordinated Healthcare Services.Ann Geriatr Med Res2025https://conductscience.org/library/papers/40195841PubMed

See all 91 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCC21244PubTator's text mininghttps://conductscience.org/library/genes/1244NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871NCBI Gene
SLC22A26582PubTator's text mininghttps://conductscience.org/library/genes/6582NCBI Gene
SLC47A155244PubTator's text mininghttps://conductscience.org/library/genes/55244NCBI Gene
SLCO1B110599PubTator's text mininghttps://conductscience.org/library/genes/10599NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32011104

GET https://conductscience.org/api/papers/v1/32011104/references?page=2